Literature DB >> 23093890

Impact of pharmacist recruitment on ADR reporting: Malaysian experience.

Muhammad Abdul Hadi1, Long Chiau Ming.   

Abstract

Entities:  

Keywords:  Adverse Drug Reactions; Malaysia; Pharmacist; Pharmacovigilance

Year:  2011        PMID: 23093890      PMCID: PMC3471183          DOI: 10.5655/smr.v4i2.1009

Source DB:  PubMed          Journal:  South Med Rev        ISSN: 1174-2704


× No keyword cloud information.

Letter to the editor

Adverse drug reactions (ADRs) pose a serious risk to the achievement of positive therapeutic outcomes [1]. Spontaneous ADR reporting, a key component of pharmacovigilance systems is not only an excellent means to document uncommon ADRs, but also allows the risk-benefit assessment for old and new medications [2,3]. Despite ADR reporting being a professional obligation, underreporting by healthcare professionals is commonplace and it is estimated that only 6% of all ADRs are reported globally [4]. Whether pharmacists have a role in national drug monitoring programmes varies by country. For example, in the United States, 70% of the ADR reports submitted to the Medical Watch programme were generated by pharmacists [5]. However, in Nordic Countries pharmacists are not in a position to directly report ADRs [6]. Malaysia has a well-organized spontaneous ADR reporting system and a postage-paid "Blue Card" is used to document and report ADRs. The blue card is accepted as the best for both ease of use and for capturing maximum data [7]. All ADR reports across Malaysia are received and screened by the Malaysian Adverse Drug Reaction Advisory Committee (MADRAC), within the National Center for Adverse Drug Reaction Monitoring [8]. The center was one of the earliest members of the World Health Drug (WHO) Safety Monitoring Program in Asia (1990), before Singapore (1993), India, and China (1998) [9]. Recently, a mechanism has been introduced to allow patient reporting of ADRs directly to MADRAC. Reports can also be submitted online via MADRAC website. Historically, underreporting of ADRs has been a serious problem in Malaysia [11]. However, the number of reports received by MADRAC has increased from 2363 in 2005 to 5850 in 2009, fulfilling WHO criteria for a reporting centre (200 reports per million of population) for first time in 2009 [10]. The sharp rise inreporting rate is mainly due to reporting by pharmacists working in the public sector. Adverse drug reaction reports generated by pharmacists increased from 726 (28.5%) in 2006 to 3357 (57.4%) in 2009 [11]. On the other hand, the contribution by physicians towards ADR reporting was 22.9% in 2009 [11]. The increase in the number of reports submitted by pharmacists could be a reflection of the increase in pharmacists working in public hospitals. In Malaysia, the number of pharmacists working in the public sector increased from 889 in 2005 to 3877 in 2009 [11]. This is likely to be due to the Malaysian Ministry of Health's requirement that before registeration with the Pharmacy Board of Malaysia, all pharmacist must complete a 4-year compulsory service in public sector. The aim of this initiative was to enhance clinical pharmacy services in public hospitals and health clinics in Malaysia. The involvement of hospital pharmacists in direct patient care appears to have triggered better detection, documentation and reporting of ADRs. The contribution of community pharmacists in ADR detection and reporting remains suboptimal and necessitates further education and training.

Authors' contribution

MAH did the literature review and wrote the initial draft. LCM provided the data related to pharmacovigilance in Malaysia and proof read the final draft.

Conflict of interest

None
  7 in total

1.  Adverse drug event monitoring at the Food and Drug Administration.

Authors:  Syed Rizwanuddin Ahmad
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

2.  Pharmacists' role in reporting adverse drug reactions in an international perspective.

Authors:  Kees van Grootheest; Sten Olsson; Mary Couper; Lolkje de Jong-van den Berg
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-07       Impact factor: 2.890

3.  Is there still a role for spontaneous reporting of adverse drug reactions?

Authors:  Joel Lexchin
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

4.  Developing a consumer reporting program in Malaysia: a novel initiative to improve pharmacovigilance.

Authors:  Subish Palaian; Mohammed Alshakka
Journal:  Pharm World Sci       Date:  2009-11-06

5.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

6.  Quality check of spontaneous adverse drug reaction reporting forms of different countries.

Authors:  M S Bandekar; S R Anwikar; N A Kshirsagar
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11       Impact factor: 2.890

Review 7.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

  7 in total
  6 in total

Review 1.  Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?

Authors:  Paul Rutter; David Brown; Justine Howard; Christine Randall
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

2.  Interplay between Oral Hypoglycemic Medication Adherence and Quality of Life among Elderly Type 2 Diabetes Mellitus Patients.

Authors:  Mohamed Mansor Manan; Akhma Radzuanna Husin; Ali Saleh Alkhoshaiban; Yaser Mohammed Ali Al-Worafi; Long Chiau Ming
Journal:  J Clin Diagn Res       Date:  2014-12-05

3.  A Retrospective Analysis of Spontaneous Adverse Drug Reactions Reports Relating to Paediatric Patients.

Authors:  Rosliana Rosli; Long Chiau Ming; Noorizan Abd Aziz; Mohamed Mansor Manan
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

Review 4.  Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting.

Authors:  Muhammad Abdul Hadi; Chin Fen Neoh; Rosdi M Zin; Mahmoud E Elrggal; Ejaz Cheema
Journal:  Integr Pharm Res Pract       Date:  2017-03-22

5.  Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.

Authors:  Yaser Mohammed Al-Worafi; Yaman Walid Kassab; Wafa Mohammed Alseragi; Masaad Saeed Almutairi; Ali Ahmed; Long Chiau Ming; Ali Saleh Alkhoshaiban; Muhammad Abdul Hadi
Journal:  Ther Clin Risk Manag       Date:  2017-09-07       Impact factor: 2.423

6.  Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia.

Authors:  Rosliana Rosli; Ahmad Fauzi Dali; Noorizan Abd Aziz; Long Chiau Ming; Mohamed Mansor Manan
Journal:  Front Pharmacol       Date:  2017-02-10       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.